SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1n81'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.44A	1v54A-1n81A: 0.9 1v54C-1n81A: 1.5	1v54A-1n81A: 14.40 1v54C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.42A	1v54N-1n81A: 0.9 1v54P-1n81A: 1.5	1v54N-1n81A: 14.40 1v54P-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.47A	1v55A-1n81A: 0.9 1v55C-1n81A: 1.6	1v55A-1n81A: 14.40 1v55C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.43A	2dyrA-1n81A: 0.9 2dyrC-1n81A: 1.6	2dyrA-1n81A: 14.40 2dyrC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.43A	2dyrN-1n81A: 0.9 2dyrP-1n81A: 1.6	2dyrN-1n81A: 14.40 2dyrP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	2dysA-1n81A: undetectable 2dysC-1n81A: undetectable	2dysA-1n81A: 14.40 2dysC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.48A	2dysN-1n81A: 0.8 2dysP-1n81A: 1.6	2dysN-1n81A: 14.40 2dysP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.48A	2eijA-1n81A: 0.7 2eijC-1n81A: 1.6	2eijA-1n81A: 14.40 2eijC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	2eijN-1n81A: 0.7 2eijP-1n81A: 1.6	2eijN-1n81A: 14.40 2eijP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	2eikA-1n81A: 0.9 2eikC-1n81A: 1.5	2eikA-1n81A: 14.40 2eikC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.44A	2eikN-1n81A: 0.7 2eikP-1n81A: 1.6	2eikN-1n81A: 14.40 2eikP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.42A	2eilA-1n81A: 1.8 2eilC-1n81A: 1.6	2eilA-1n81A: 14.40 2eilC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.43A	2eilN-1n81A: 0.9 2eilP-1n81A: 1.6	2eilN-1n81A: 14.40 2eilP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.43A	2eimN-1n81A: 0.1 2eimP-1n81A: 1.6	2eimN-1n81A: 14.40 2eimP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.48A	2einA-1n81A: 1.0 2einC-1n81A: 0.9	2einA-1n81A: 14.40 2einC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_A_CHDA1517_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	2y69A-1n81A: 0.8 2y69C-1n81A: 1.6	2y69A-1n81A: 14.40 2y69C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.47A	2zxwA-1n81A: 0.9 2zxwC-1n81A: 0.9	2zxwA-1n81A: 14.40 2zxwC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.44A	3abkA-1n81A: 0.8 3abkC-1n81A: 0.9	3abkA-1n81A: 14.40 3abkC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.44A	3abkN-1n81A: 0.8 3abkP-1n81A: 1.6	3abkN-1n81A: 14.40 3abkP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.41A	3ag1A-1n81A: 0.2 3ag1C-1n81A: 0.9	3ag1A-1n81A: 14.40 3ag1C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.42A	3ag1N-1n81A: 1.7 3ag1P-1n81A: 0.8	3ag1N-1n81A: 14.40 3ag1P-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	3ag2A-1n81A: 0.7 3ag2C-1n81A: 1.5	3ag2A-1n81A: 14.40 3ag2C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	3ag2N-1n81A: 0.8 3ag2P-1n81A: 0.8	3ag2N-1n81A: 14.40 3ag2P-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.47A	3ag3A-1n81A: 0.7 3ag3C-1n81A: 0.8	3ag3A-1n81A: 14.40 3ag3C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.43A	3ag3N-1n81A: 0.8 3ag3P-1n81A: 0.9	3ag3N-1n81A: 14.40 3ag3P-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.47A	3ag4A-1n81A: 0.0 3ag4C-1n81A: 1.5	3ag4A-1n81A: 14.40 3ag4C-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.48A	3ag4N-1n81A: 0.3 3ag4P-1n81A: 0.9	3ag4N-1n81A: 14.40 3ag4P-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	3asnA-1n81A: 0.7 3asnC-1n81A: 0.9	3asnA-1n81A: 14.40 3asnC-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB3_A_SAMA1101_0 (STRUCTURAL PROTEIN VP3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	5 / 12	GLU A 42 GLU A 129 ARG A 34 VAL A 194 ASN A 96	None	1.09A	3jb3A-1n81A: 0.0	3jb3A-1n81A: 10.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R55_A_PZAA598_0 (LACTOPEROXIDASE)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	3 / 3	GLU A 42 PHE A 189 GLN A 130	None	1.01A	3r55A-1n81A: 1.4	3r55A-1n81A: 13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A97_I_ZPCI1318_2 (CYS-LOOP LIGAND-GATED ION CHANNEL)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	GLU A 42 ILE A 101 PHE A 43 VAL A 172	None	1.21A	4a97I-1n81A: 3.1	4a97I-1n81A: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.44A	5b1aN-1n81A: 0.7 5b1aP-1n81A: 1.5	5b1aN-1n81A: 14.40 5b1aP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	5b1bN-1n81A: 0.7 5b1bP-1n81A: 0.9	5b1bN-1n81A: 14.40 5b1bP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.44A	5b3sN-1n81A: 0.7 5b3sP-1n81A: 1.6	5b3sN-1n81A: 14.40 5b3sP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.46A	5iy5A-1n81A: 0.9 5iy5C-1n81A: 1.5	5iy5A-1n81A: 14.40 5iy5C-1n81A: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.45A	5x19N-1n81A: 0.8 5x19P-1n81A: 0.8	5x19N-1n81A: 14.40 5x19P-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.45A	5x1bN-1n81A: 0.8 5x1bP-1n81A: 0.8	5x1bN-1n81A: 14.40 5x1bP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.43A	5x1fN-1n81A: 0.7 5x1fP-1n81A: 0.9	5x1fN-1n81A: 14.40 5x1fP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 7	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.45A	5zcqN-1n81A: 0.7 5zcqP-1n81A: 0.9	5zcqN-1n81A: 14.40 5zcqP-1n81A: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	1n81	PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27/25 (Plasmodium falciparum)	4 / 6	ASP A 164 THR A 165 TYR A 168 HIS A 28	None	1.45A	6nknA-1n81A: undetectable 6nknC-1n81A: 0.8	6nknA-1n81A: 14.40 6nknC-1n81A: 20.51

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1V54_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.44A","1v54A-1n81A:0.9;1v54C-1n81A:1.5","1v54A-1n81A:14.40;1v54C-1n81A:20.51"],["1V54_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.42A","1v54N-1n81A:0.9;1v54P-1n81A:1.5","1v54N-1n81A:14.40;1v54P-1n81A:20.51"],["1V55_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.47A","1v55A-1n81A:0.9;1v55C-1n81A:1.6","1v55A-1n81A:14.40;1v55C-1n81A:20.51"],["2DYR_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.43A","2dyrA-1n81A:0.9;2dyrC-1n81A:1.6","2dyrA-1n81A:14.40;2dyrC-1n81A:20.51"],["2DYR_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.43A","2dyrN-1n81A:0.9;2dyrP-1n81A:1.6","2dyrN-1n81A:14.40;2dyrP-1n81A:20.51"],["2DYS_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","2dysA-1n81A:undetectable;2dysC-1n81A:undetectable","2dysA-1n81A:14.40;2dysC-1n81A:20.51"],["2DYS_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.48A","2dysN-1n81A:0.8;2dysP-1n81A:1.6","2dysN-1n81A:14.40;2dysP-1n81A:20.51"],["2EIJ_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.48A","2eijA-1n81A:0.7;2eijC-1n81A:1.6","2eijA-1n81A:14.40;2eijC-1n81A:20.51"],["2EIJ_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","2eijN-1n81A:0.7;2eijP-1n81A:1.6","2eijN-1n81A:14.40;2eijP-1n81A:20.51"],["2EIK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","2eikA-1n81A:0.9;2eikC-1n81A:1.5","2eikA-1n81A:14.40;2eikC-1n81A:20.51"],["2EIK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.44A","2eikN-1n81A:0.7;2eikP-1n81A:1.6","2eikN-1n81A:14.40;2eikP-1n81A:20.51"],["2EIL_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.42A","2eilA-1n81A:1.8;2eilC-1n81A:1.6","2eilA-1n81A:14.40;2eilC-1n81A:20.51"],["2EIL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.43A","2eilN-1n81A:0.9;2eilP-1n81A:1.6","2eilN-1n81A:14.40;2eilP-1n81A:20.51"],["2EIM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.43A","2eimN-1n81A:0.1;2eimP-1n81A:1.6","2eimN-1n81A:14.40;2eimP-1n81A:20.51"],["2EIN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.48A","2einA-1n81A:1.0;2einC-1n81A:0.9","2einA-1n81A:14.40;2einC-1n81A:20.51"],["2Y69_A_CHDA1517_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","2y69A-1n81A:0.8;2y69C-1n81A:1.6","2y69A-1n81A:14.40;2y69C-1n81A:20.51"],["2ZXW_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.47A","2zxwA-1n81A:0.9;2zxwC-1n81A:0.9","2zxwA-1n81A:14.40;2zxwC-1n81A:20.51"],["3ABK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.44A","3abkA-1n81A:0.8;3abkC-1n81A:0.9","3abkA-1n81A:14.40;3abkC-1n81A:20.51"],["3ABK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.44A","3abkN-1n81A:0.8;3abkP-1n81A:1.6","3abkN-1n81A:14.40;3abkP-1n81A:20.51"],["3AG1_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.41A","3ag1A-1n81A:0.2;3ag1C-1n81A:0.9","3ag1A-1n81A:14.40;3ag1C-1n81A:20.51"],["3AG1_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.42A","3ag1N-1n81A:1.7;3ag1P-1n81A:0.8","3ag1N-1n81A:14.40;3ag1P-1n81A:20.51"],["3AG2_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","3ag2A-1n81A:0.7;3ag2C-1n81A:1.5","3ag2A-1n81A:14.40;3ag2C-1n81A:20.51"],["3AG2_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","3ag2N-1n81A:0.8;3ag2P-1n81A:0.8","3ag2N-1n81A:14.40;3ag2P-1n81A:20.51"],["3AG3_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.47A","3ag3A-1n81A:0.7;3ag3C-1n81A:0.8","3ag3A-1n81A:14.40;3ag3C-1n81A:20.51"],["3AG3_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.43A","3ag3N-1n81A:0.8;3ag3P-1n81A:0.9","3ag3N-1n81A:14.40;3ag3P-1n81A:20.51"],["3AG4_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.47A","3ag4A-1n81A:0.0;3ag4C-1n81A:1.5","3ag4A-1n81A:14.40;3ag4C-1n81A:20.51"],["3AG4_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.48A","3ag4N-1n81A:0.3;3ag4P-1n81A:0.9","3ag4N-1n81A:14.40;3ag4P-1n81A:20.51"],["3ASN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","3asnA-1n81A:0.7;3asnC-1n81A:0.9","3asnA-1n81A:14.40;3asnC-1n81A:20.51"],["3JB3_A_SAMA1101_0","STRUCTURAL PROTEIN VP3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",5,"GLU A  42;GLU A 129;ARG A  34;VAL A 194;ASN A  96","None","1.09A","3jb3A-1n81A:0.0","3jb3A-1n81A:10.57"],["3R55_A_PZAA598_0","LACTOPEROXIDASE","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",3,"GLU A  42;PHE A 189;GLN A 130","None","1.01A","3r55A-1n81A:1.4","3r55A-1n81A:13.47"],["4A97_I_ZPCI1318_2","CYS-LOOP LIGAND-GATED ION CHANNEL","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"GLU A  42;ILE A 101;PHE A  43;VAL A 172","None","1.21A","4a97I-1n81A:3.1","4a97I-1n81A:20.00"],["5B1A_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.44A","5b1aN-1n81A:0.7;5b1aP-1n81A:1.5","5b1aN-1n81A:14.40;5b1aP-1n81A:20.51"],["5B1B_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","5b1bN-1n81A:0.7;5b1bP-1n81A:0.9","5b1bN-1n81A:14.40;5b1bP-1n81A:20.51"],["5B3S_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.44A","5b3sN-1n81A:0.7;5b3sP-1n81A:1.6","5b3sN-1n81A:14.40;5b3sP-1n81A:20.51"],["5IY5_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.46A","5iy5A-1n81A:0.9;5iy5C-1n81A:1.5","5iy5A-1n81A:14.40;5iy5C-1n81A:20.82"],["5X19_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.45A","5x19N-1n81A:0.8;5x19P-1n81A:0.8","5x19N-1n81A:14.40;5x19P-1n81A:20.51"],["5X1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.45A","5x1bN-1n81A:0.8;5x1bP-1n81A:0.8","5x1bN-1n81A:14.40;5x1bP-1n81A:20.51"],["5X1F_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.43A","5x1fN-1n81A:0.7;5x1fP-1n81A:0.9","5x1fN-1n81A:14.40;5x1fP-1n81A:20.51"],["5ZCQ_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.45A","5zcqN-1n81A:0.7;5zcqP-1n81A:0.9","5zcqN-1n81A:14.40;5zcqP-1n81A:20.51"],["6NKN_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","1n81","PLASMODIUM FALCIPARUM GAMETE ANTIGEN 27\/25","Plasmodium falciparum",4,"ASP A 164;THR A 165;TYR A 168;HIS A  28","None","1.45A","6nknA-1n81A:undetectable;6nknC-1n81A:0.8","6nknA-1n81A:14.40;6nknC-1n81A:20.51"]]